GTN Companies
GTN is an organization that focuses on innovating quantum machine learning technology to revolutionize drug discovery. With the rising costs and diminishing returns of traditional drug development, GTN aims to address this challenge by searching for new drug-like molecules using their patented technology called Generative Tensorial Networks. By combining machine learning and quantum physics techniques, their software is able to simulate, filter, and search for molecules in a more efficient and cost-effective manner. GTN's approach has the potential to significantly reduce development costs and uncover hidden molecules that may have been overlooked using traditional methods.
Investors
Headquarters:
London, England, United Kingdom
Founded Date:
2017
Employee Number:
1-10
Industry:
Advanced BioTech R&D
Technology:
AI R&D Pharma (DPI)